Bowden RG - Search Results

1

Low relative skeletal muscle mass indicative of sarcopenia is associated with elevations in serum uric acid levels: findings from NHANES III.

Beavers KM, Beavers DP, Serra MC, Bowden RG, Wilson RL. Beavers KM, et al. Among authors: bowden rg. J Nutr Health Aging. 2009 Mar;13(3):177-82. doi: 10.1007/s12603-009-0054-5. J Nutr Health Aging. 2009. PMID: 19262948 Free article.

2

Homocysteine and vascular access thrombosis in end-stage renal disease patients: a retrospective study.

Bowden RG, Wyatt FB, Wilson R. Bowden RG, et al. J Nephrol. 2002 Nov-Dec;15(6):666-70. J Nephrol. 2002. PMID: 12495281

3

Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients.

Bowden RG, Wyatt FB, Wilson R, Wilborn C, Gentile M. Bowden RG, et al. Ren Fail. 2004 Nov;26(6):709-14. doi: 10.1081/jdi-200037117. Ren Fail. 2004. PMID: 15600264 Free article.

4

Effects of omega-3 fatty acid supplementation on vascular access thrombosis in polytetrafluorethylene grafts.

Bowden RG, Wilson RL, Gentile M, Ounpraseuth S, Moore P, Leutholtz BC. Bowden RG, et al. J Ren Nutr. 2007 Mar;17(2):126-31. doi: 10.1053/j.jrn.2006.07.009. J Ren Nutr. 2007. PMID: 17321952 Clinical Trial.

5

Comparison of lipid measures and risk stratification among end-stage renal disease patients.

Bowden RG, Hebert S, Wilson R, Gentile M, Lanning BA. Bowden RG, et al. J Nephrol. 2007 Mar-Apr;20(2):212-8. J Nephrol. 2007. PMID: 17514626

6

Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.

Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Beavers KM, et al. Among authors: bowden rg. Nephrology (Carlton). 2008 Jun;13(4):284-8. doi: 10.1111/j.1440-1797.2008.00934.x. Epub 2008 Mar 5. Nephrology (Carlton). 2008. PMID: 18331436 Clinical Trial.

7

Fish oil supplementation lowers C-reactive protein levels independent of triglyceride reduction in patients with end-stage renal disease.

Bowden RG, Wilson RL, Deike E, Gentile M. Bowden RG, et al. Nutr Clin Pract. 2009 Aug-Sep;24(4):508-12. doi: 10.1177/0884533609335376. Epub 2009 May 21. Nutr Clin Pract. 2009. PMID: 19461006 Clinical Trial.

8

Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.

Bowden RG, Jitomir J, Wilson RL, Gentile M. Bowden RG, et al. J Ren Nutr. 2009 Jul;19(4):259-66. doi: 10.1053/j.jrn.2009.01.030. J Ren Nutr. 2009. PMID: 19539180 Clinical Trial.

9

Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.

Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M. Beavers KM, et al. Among authors: bowden rg. J Ren Nutr. 2009 Nov;19(6):443-9. doi: 10.1053/j.jrn.2009.06.005. Epub 2009 Sep 12. J Ren Nutr. 2009. PMID: 19748798 Clinical Trial.

10

The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.

Shelmadine B, Bowden RG, Wilson RL, Beavers D, Hartman J. Shelmadine B, et al. Among authors: bowden rg. Anadolu Kardiyol Derg. 2009 Oct;9(5):385-9. Anadolu Kardiyol Derg. 2009. PMID: 19819789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters